Nuclear IGF-1R autoregulates its own expression in breast cancer cells depending on their estrogen receptor (ER) status (102) and binds the LEF1 transcription factor, which subsequently leads to upregulated cyclinD1 and axin 2 and cell proliferation (56). The gene discussed is IGF1R; the disease is breast carcinoma.